NCT06587698View on ClinicalTrials.gov

Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

August 21, 2024

Primary Completion Date

July 1, 2028

Study Completion Date

July 1, 2029

Conditions
Polycystic Ovarian Syndrome
Interventions
DRUG

Sitagliptin

100 mg QD for 3 month

DRUG

BeiDouGen

60 mg BID for 3 month

DRUG

Sitagliptin+BeiDouGen

100 mg Sitagliptin QD plus BeiDouGen 60 mg BID for 3 month

Trial Locations (1)

100000

RECRUITING

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER